For all their importance as a breakthrough treatment, the cancer immunotherapies known as checkpoint inhibitors still only benefit a small minority of patients, perhaps 15 percent […]
Researchers at the Centre for Genomic Regulation (CRG) reveal that newly formed embryos clear dying cells to maximize their chances of survival. It is the earliest […]